Form 4: Cardio Diagnostics Director Stanley Lau Settles Restricted Stock Units

Director Stanley Lau settled restricted stock units for Cardio Diagnostics Holdings, Inc. on March 31, 2024, resulting in the acquisition of 8,803 shares of common stock.

Summary

• On March 31, 2024, Stanley Lau, a director of Cardio Diagnostics Holdings, Inc., settled restricted stock units (RSUs).
• This transaction resulted in the acquisition of 8,803 shares of common stock at a price of $1.42 per share.
• Following the transaction, Lau directly owns 100,325 shares of Cardio Diagnostics Holdings, Inc.
• The RSUs were granted pursuant to the Issuer's 2022 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the transaction itself is a standard part of executive compensation. Therefore, the sentiment is neutral.

Positives

• The settlement of RSUs indicates that Lau is receiving compensation in the form of company stock, aligning his interests with those of shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects the ongoing compensation of a company director.

Key Dates